- Work
- Life Sciences
Licensed science, turned into measurable engagement.
MedEngage gives pharmaceutical and medical-affairs teams — and the medcomms agencies that support them — a single environment for assembling approved evidence and deploying it across every campaign, congress, and market. Logicbomb Media engineered and designed the entire platform on Nuxt.
Compliant, substantiated — and impossible to stitch together.
The problem MedEngage addresses is specific to how pharma communicates. Medical-affairs and brand teams work with large libraries of licensed scientific evidence, and every message they put forward needs to be both compliant and substantiated — with measurable proof that it actually reached and engaged its audience.
Stitching that together across campaigns, congresses, and individual markets has traditionally been manual, fragmented, and hard to measure. MedEngage gives those teams one place to do it well.
From licensed assets to evidence experiences.
A journal article on its own is just a PDF. MedEngage lets pharma assemble many licensed assets into structured, evidence-based experiences — pulling the right peer-reviewed science together and putting it in front of healthcare professionals in a controlled, trackable way.
It is the deployment-and-engagement side of the same world Engraffo serves from the publisher side — and the second product Logicbomb Media has built for Ibis Labs.
Claim-to-evidence mapping
The standout capability: a clear way to show where each claim a pharma team makes is actually supported by the underlying science — exactly the kind of substantiation the industry lives and dies by.
Measured engagement
Compliant access controls govern every experience, and real HCP engagement is measured throughout. An AI layer built on OpenAI turns visitors’ real actions into readable reports, with PostHog powering the underlying product analytics.
Logicbomb Media handled all of the engineering and product design — a from-scratch build on Nuxt, with an OpenAI-powered reporting layer and PostHog product analytics. Ibis Labs owns the business; LBM built the product from the ground up.
Both sides of the evidence equation.
MedEngage is currently in beta, rolling out with early pharma and medcomms users — a from-scratch build that extends LBM’s Ibis Labs partnership from one category-leading product into a second.
Together, Engraffo and MedEngage cover both sides of scientific-evidence engagement: the publishers who own the content, and the pharmaceutical teams who put it to work.
Purpose-built platforms start with one conversation.
Purpose-built platforms start with one conversation.